Biomimetic fabrication of nanotherapeutics by leukocyte membrane cloaking for targeted therapy.
Colloids Surf B Biointerfaces
; 219: 112803, 2022 Aug 24.
Article
in English
| MEDLINE | ID: covidwho-2031218
ABSTRACT
Cell membrane cloaking is an important biomimetic approach for improving drug residence time in the body due to its distinctive concealment ability, making it highly biocompatible and efficient for targeted drug delivery. Leukocytes are considered a fundamental part of the immune system. Leukocyte membrane cloaked nanoparticles offer site-specificity and can escape the opsonization process besides enhanced systemic circulation time. This review emphasizes the anatomical and physiological features of different leukocytes in addition to the preparation and characterization of leukocyte membrane cloaked nanoparticles. It also covers the recent advancements of this biointerfacing platform in cancer therapy, inflammatory disorders, multifunctional targeted therapy and hybrid membrane-coated nanoparticles. However, leukocytes are complex, nucleated cell structures and isolating their membranes poses a greater difficulty. Leukocyte membrane cloaking is an upcoming strategy in the infancy stage; nevertheless, there is immense scope to explore this biomimetic delivery system in terms of clinical transition, particularly for inflammatory diseases and cancer.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Colloids Surf B Biointerfaces
Journal subject:
Chemistry
Year:
2022
Document Type:
Article
Affiliation country:
J.colsurfb.2022.112803
Similar
MEDLINE
...
LILACS
LIS